Ian Pirker
Anti-S1 Antibodies After Vaccination with Anti SARS-CoV-2 mRNA Vaccines in Patients with Rheumatoid Arthritis Differ in Magnitude and Kinetics from Healthy Controls: Results from a Prospective, Observational Controlled Study
Rubbert-Roth A, Vuilleumier N, Ludewig B, Schmiedeberg K, Rottländer Y, Pirker I, von Kempis J (2022). Anti-S1 Antibodies After Vaccination with Anti SARS-CoV-2 mRNA Vaccines in Patients with Rheumatoid Arthritis Differ in Magnitude and Kinetics from Healthy Controls: Results from a Prospective, Observational Controlled Study.
Dec 28, 2021Anti-S1 Antibodies After Vaccination with Anti SARS-CoV-2 mRNA Vaccines in Patients with Rheumatoid Arthritis Differ in Magnitude and Kinetics from Healthy Controls: Results from a Prospective, Observational Controlled Study
Dec 28, 2021ACR Converence 2021
Rubbert-Roth Andrea, Vuilleumier Nicolas, Ludewig Burkhard, Schmiedeberg Kristin, Rottländer Yella, Pirker Ian, von Kempis Johannes
Clinical Image: In vivo urate spherulites in a patient with gout
Pirker I, Nussberger M, von Kempis J. Clinical Image: In vivo urate spherulites in a patient with gout. ACR Open Rheumatol 2021; 3:888.
Sep 23, 2021Clinical Image: In vivo urate spherulites in a patient with gout
Sep 23, 2021ACR Open Rheumatol 2021; 3:888
Pirker Ian, Nussberger Madalina, von Kempis Johannes
Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus
Pirker I, Saulite I, von Kempis J. Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus. ACR Open Rheumatol 2021; 3:41.
Jan 3, 2021Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus
Jan 3, 2021ACR Open Rheumatol 2021; 3:41
Pirker Ian, Saulite Ieva, von Kempis Johannes
Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy
Pirker I, Rubbert-Roth A, von Kempis J, Fehr M, Neumann T. Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy. Clin Exp Rheumatol 2020
Jan 28, 2020Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy
Jan 28, 2020Clin Exp Rheumatol 2020
Pirker Ian, Rubbert-Roth Andrea, von Kempis Johannes, Fehr Martin, Neumann Thomas
Aktue Nackenschmerzen mit seltener Ursache
Pirker I. Aktue Nackenschmerzen mit seltener Ursache. Swiss Med Forum 2020; 20(0304):50-52.
Jan 15, 2020Aktue Nackenschmerzen mit seltener Ursache
Jan 15, 2020Swiss Med Forum 2020; 20(0304):50-52
Pirker Ian